Menopur Description

Appearance of powder: white to off-white lyophilisation cake.
Appearance of solvent: clear and colourless solution.
Human Chorionic Gonadotrophin (hCG), a naturally occurring hormone in postmenopausal urine, is present in MENOPUR and is the main contributor of the LH activity.
MENOPUR 75 IU: Each vial with powder contains highly purified Menotrophin (human menopausal gonadotrophin, HMG) corresponding to follicle stimulating hormone activity FSH 75 IU and luteinizing hormone activity LH 75 IU. After reconstitution of one vial, 1 mL of the reconstituted solution contains 75 IU of highly purified menotrophin.
Reconstituted solution: The mixed powder and solvent has a pH value of 5.0-7.0 (release limit) and pH value of 5.0-8.0 (shelf-life limit).
MENOPUR 600 IU: Each vial with powder contains highly purified menotrophin (human menopausal gonadotrophin, HMG) corresponding to follicle stimulating hormone activity FSH 600 IU and luteinizing hormone activity LH 600 IU.
MENOPUR 1200 IU: Each vial with powder contains highly purified menotrophin (human menopausal gonadotrophin, HMG) corresponding to follicle stimulating hormone activity FSH 1200 IU and luteinizing hormone activity LH 1200 IU.
Excipients/Inactive Ingredients: 75 IU: Powder: Lactose monohydrate, polysorbate 20, sodium hydroxide, hydrochloric acid.
Solvent: Sodium chloride, hydrochloric acid, water for injections.
600 IU and 1200 IU: Powder: Lactose monohydrate, polysorbate 20, sodium phosphate dibasic heptahydrate, phosphoric acid (concentrated).
Solvent: Metacresol, water for injection.